NFATc3 pathway participates in the process that 15-LO/15-HETE protects pulmonary artery smooth muscle cells against apoptosis during hypoxia

References

• Yu Y, Fantozzi I, Remillard CV, et al. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci U S A 2004;101:13861–6
   PubMed Web of Science ®Google Scholar
• Lin MJ, Leung GP, Zhang WM, et al. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 2004;95:496–505
   PubMed Web of Science ®Google Scholar
• Wang J, Juhaszova M, Rubin LJ, Yuan XJ. Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells. J Clin Invest 1997;100:2347–53
   Google Scholar
• Jernigan NL, Walker BR, Resta TC. Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling. Am J Physiol Lung Cell Mol Physiol 2004;287:L1220–9
   Google Scholar
• Abe K, Shimokawa H, Morikawa K, et al. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 2004;94:385–93
   PubMed Web of Science ®Google Scholar
• de Frutos S, Spangler R, Alo D, Bosc LV. NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation. J Biol Chem 2007;282:15081–9
   PubMed Web of Science ®Google Scholar
• Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431–8
   PubMed Web of Science ®Google Scholar
• Uhal BD. Apoptosis in lung fibrosis and repair. Chest 2002;122:293S–8S
   PubMed Web of Science ®Google Scholar
• Zhang S, Fantozzi I, Tigno DD, et al. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003;285:L740–54
   PubMed Web of Science ®Google Scholar
• Cowan KN, Jones PL, Rabinovitch M. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 1999;84:1223–33
   Google Scholar
• Cowan KN, Heilbut A, Humpl T, et al. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 2000;6:698–702
   PubMed Web of Science ®Google Scholar
• Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005;5:472–84
   PubMed Web of Science ®Google Scholar
• Graef IA, Chen F, Crabtree GR. NFAT signaling in vertebrate development. Curr Opin Genet Dev 2001;11:505–12
   PubMed Web of Science ®Google Scholar
• Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707–47
   PubMed Web of Science ®Google Scholar
• Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003;17:2205–32
   PubMed Web of Science ®Google Scholar
• Schulz RA, Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 2004;266:1–16
   PubMed Web of Science ®Google Scholar
• Graef IA, Chen F, Chen L, et al. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001;105:863–75
   PubMed Web of Science ®Google Scholar
• Amberg GC, Rossow CF, Navedo MF, Santana LF. NFATc3 regulates Kv2.1 expression in arterial smooth muscle. J Biol Chem 2004;279:47326–34
   PubMed Web of Science ®Google Scholar
• de Frutos S, Nitta CH, Caldwell E, et al. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR. Am J Physiol Lung Cell Mol Physiol. 2009;297:L475–86
   PubMed Web of Science ®Google Scholar
• Nieves-Cintron M, Amberg GC, Nichols CB, et al. Activation of NFATc3 down-regulates the beta1 subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension. J Biol Chem 2007;282:3231–40
   PubMedGoogle Scholar
• Urso K, Alfranca A, Martinez-Martinez S, et al. NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis. Blood 2011;118:795–803
   PubMedGoogle Scholar
• Bierer R, Nitta CH, Friedman J, et al. NFATc3 is required for chronic hypoxia-induced pulmonary hypertension in adult and neonatal mice. Am J Physiol Lung Cell Mol Physiol 2011;301:L872–80
   PubMed Web of Science ®Google Scholar
• Bonnet S, Rochefort G, Sutendra G, et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci USA 2007;104:11418–23
   PubMed Web of Science ®Google Scholar
• Gomez-Sintes R, Lucas JJ. NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy. J Clin Invest 2010;120:2432–45
   Google Scholar
• Butterick TA, Igbavboa U, Eckert GP, et al. Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol 2010;41:384–91
   Google Scholar
• Zhu D, Medhora M, Campbell WB, et al. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res 2003;92:992–1000
   PubMed Web of Science ®Google Scholar
• Ma J, Liang S, Wang Z, et al. ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. J Cell Physiol 2010;222:82–94
   Google Scholar
• Ma C, Li Y, Ma J, et al. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension. Hypertension 2011;58:679–88
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma C, Zhang Q, et al. The key role of transforming growth factor-beta receptor I and 15-lipoxygenase in hypoxia-induced proliferation of pulmonary artery smooth muscle cells. Int J Biochem Cell Biol 2012;44:1184–202
   PubMed Web of Science ®Google Scholar
• Jiang J, Wang S, Wang Z, et al. The role of ERK1/2 in 15-HETE-inhibited apoptosis in pulmonary arterial smooth muscle cells. J Recept Signal Transduct Res 2011;31:45–52
   PubMed Web of Science ®Google Scholar
• Wang S, Wang Y, Jiang J, et al. 15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K/Akt pathway. Prostaglandins Other Lipid Mediat 2010;91:51–60
   PubMed Web of Science ®Google Scholar
• Li Y, Li Q, Wang Z, et al. 15-HETE suppresses K(+) channel activity and inhibits apoptosis in pulmonary artery smooth muscle cells. Apoptosis 2009;14:42–51
   PubMed Web of Science ®Google Scholar
• Blumberg FC, Wolf K, Arzt M, et al. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs. J Appl Physiol 2003;94:446–52
   PubMedGoogle Scholar
• Ferri C, Bellini C, De Angelis C, et al. Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol 1995;48:519–24
   PubMedGoogle Scholar
• Yang X, Chen W, Chen J. Change of level and expression of endothelin-1 in the lungs of rats with hypoxic pulmonary hypertension. Chin Med J (Engl) 1997;110:104–8
   Google Scholar
• de Frutos S, Diaz JM, Nitta CH, et al. Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries. Am J Physiol Cell Physiol 2011;301:C441–50
   PubMed Web of Science ®Google Scholar
• Pisarcik S, Maylor J, Lu W, et al. Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1. Am J Physiol Lung Cell Mol Physiol 2013;304:L549–61
   Google Scholar
• Li M, Liu Y, Jin F, et al. Endothelin-1 induces hypoxia inducible factor 1alpha expression in pulmonary artery smooth muscle cells. FEBS Lett 2012;586:3888–93
   PubMed Web of Science ®Google Scholar
• Wu T, Mullol J, Rieves RD, et al. Endothelin-1 stimulates eicosanoid production in cultured human nasal mucosa. Am J Respir Cell Mol Biol 1992;6:168–74
   PubMed Web of Science ®Google Scholar
• Yao L, Nie X, Shi S, et al. Reciprocal regulation of HIF-1alpha and 15-LO/15-HETE promotes anti-apoptosis process in pulmonary artery smooth muscle cells during hypoxia. Prostaglandins Other Lipid Mediat 2012;99:96–106
   Google Scholar
• Li S, Ran Y, Zheng X, et al. 15-HETE mediates sub-acute hypoxia-induced TRPC1 expression and enhanced capacitative calcium entry in rat distal pulmonary arterial myocytes. Prostaglandins Other Lipid Mediat 2010;93:60–74
   Google Scholar
• Chu X, Tang X, Guo L, et al. Hypoxia suppresses KV1.5 channel expression through endogenous 15-HETE in rat pulmonary artery. Prostaglandins Other Lipid Mediat 2009;88:42–50
   Google Scholar
• Wang C, Li JF, Zhao L, et al. Inhibition of SOC/Ca2+/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells. Respir Res 2009;10:123
   PubMed Web of Science ®Google Scholar
• Rossow CF, Minami E, Chase EG, et al. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circ Res 2004;94:1340–50
   Google Scholar
• Kawamura T, Ono K, Morimoto T, et al. Endothelin-1-dependent nuclear factor of activated T lymphocyte signaling associates with transcriptional coactivator p300 in the activation of the B cell leukemia-2 promoter in cardiac myocytes. Circ Res 2004;94:1492–9
   PubMed Web of Science ®Google Scholar
• Luoma JI, Zirpel L. Deafferentation-induced activation of NFAT (nuclear factor of activated T-cells) in cochlear nucleus neurons during a developmental critical period: a role for NFATc4-dependent apoptosis in the CNS. J Neurosci 2008;28:3159–69
   Google Scholar
• Rinne A, Kapur N, Molkentin JD, et al. Isoform- and tissue-specific regulation of the Ca(2+)-sensitive transcription factor NFAT in cardiac myocytes and heart failure. Am J Physiol Heart Circ Physiol 2010;298:H2001–9
   Google Scholar